医学
危险系数
前瞻性队列研究
比例危险模型
人口学
置信区间
人口
流行病学
队列研究
死亡率
队列
老年学
内科学
环境卫生
社会学
作者
Paolo Boffetta,Farhad Islami,Rajesh Vedanthan,Akram Pourshams,Farin Kamangar,Hooman Khademi,Arash Etemadi,Rasool Salahi,Shahryar Semnani,Ashkan Emadi,Christian C. Abnet,Paul M. Brennan,Paul D.P. Pharoah,Sanford M. Dawsey,Reza Malekzadeh
摘要
Only a limited number of studies have investigated the correlation between haematocrit (HCT) and mortality in the general population, and few of those studies have had data on a wide range of low and high levels of HCT. We investigated the association between baseline HCT and mortality in a prospective cohort study of 49,983 adult subjects in Iran with a broad spectrum of HCT values.Data on socio-demographic and life-style factors, past medical history, and levels of HCT were collected at enrollment. During a mean follow-up of 5 years (follow-up success rate ~99%), 2262 deaths were reported. Cox proportional hazards regression models were used to estimate hazard ratios and corresponding 95% confidence intervals.There was a U-shaped relationship between categories of HCT and mortality in both sexes: both low and high levels of HCT were associated with increased overall mortality and mortality from cardiovascular disease. The U-shaped relationship persisted after several sensitivity analyses were done, including analyses restricted to non-smokers and non-users of opium; analyses excluding deaths from accidents and other external causes as well as deaths of persons with self-reported ischemic heart disease at the baseline interview for the study; and analyses excluding the first 2 years of follow-up. Self-reported past medical history and lack of data about lipids and other cellular blood components were the major limitations of the study.Low and high levels of HCT are associated with increased mortality in the general population. The findings in the present study can be of particular importance for low- and middle-income countries in which a substantial proportion of the population lives with suboptimal levels of HCT.
科研通智能强力驱动
Strongly Powered by AbleSci AI